Santai Song

8 Dongda Street
Beijing, 100071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

CDKN2A inhibits formation of homotypic cell-in-cell structures.

CDKN2A inhibits formation of homotypic cell-in-cell structures.

Journal: Oncogenesis

Published: December 11, 2017

A nomogram for predicting survival in patients with breast cancer brain metastasis.

A nomogram for predicting survival in patients with breast cancer brain metastasis.

Journal: Oncology letters

Published: February 07, 2017

Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.

Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.

Journal: Oncotarget

Published: January 17, 2017

Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report.

Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report.

Journal: OncoTargets and therapy

Published: July 23, 2016

Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer.

Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer.

Journal: Oncotarget

Published: July 02, 2016

Receptor conversion in metastatic breast cancer: a prognosticator of survival.

Receptor conversion in metastatic breast cancer: a prognosticator of survival.

Journal: Oncotarget

Published: June 09, 2016

Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer.

Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer.

Journal: Clinical and experimental pharmacology & physiology

Published: March 06, 2016

Sunitinib as salvage treatment including potent anti-tumor activity in carcinomatous ulcers for patients with multidrug-resistant metastatic breast cancer.

Sunitinib as salvage treatment including potent anti-tumor activity in carcinomatous ulcers for patients with multidrug-resistant metastatic breast cancer.

Journal: Oncotarget

Published: January 15, 2016

PTEN loss correlates withthe clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance

PTEN loss correlates withthe clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance

Journal: Zhonghua yi xue za zhi

Published: December 30, 2015

Clinical efficacy and safety of trastuzumab plus capecitabine as first-line therapy for HER-2 positive metastatic breast cancer

Clinical efficacy and safety of trastuzumab plus capecitabine as first-line therapy for HER-2 positive metastatic breast cancer

Journal: Zhonghua yi xue za zhi

Published: December 30, 2015

National consensus in China on diagnosis and treatment of patients with advanced breast cancer.

National consensus in China on diagnosis and treatment of patients with advanced breast cancer.

Journal: Annals of translational medicine

Published: November 26, 2015

Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer.

Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 06, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026